PUBLICATIONS You can learn more about our research and development through scientific publications and presentations from the Aeglea team and our collaborators. Select a Program ALL Arginase 1 Deficiency Homocystinuria June 2022 Health Care Resource Utilization in the Management of Patients with Arginase 1 Deficiency in the US: A Retrospective, Observational, Claims Database Study Aseel Bin Sawad, John Jackimiec, Mark Bechter, Michael Hull, Jason Yeaw, Yi Wang & George A. Diaz JME, Journal of Medical Economics April 2022 Pegzilarginase in Arginase 1 Deficiency: Results of the PEACE Pivotal Phase 3 Clinical Trial Gregory M. Enns, MB, ChB; Rossana Sanchez Russo, MD; Eric Bradford, MD, MSc, MBA; Gillian Bubb, PhD; Leslie S. Sloan, PhD; Serena Gasperini, MD; George A. Diaz, MD, PhD Society for Inherited Metabolic Disorders Annual Meeting March 2022 Pre-Analytical Considerations Are Important In The Pharmacological Assessment Of Enzyme Therapeutics Kevin Thorneloe, Chris Daige, Jason Wiggins, Leslie Priddy, Jess Van Cleef, Silvia Ferrati, Leslie Sloan, and Scott Rowlinson ACMG Annual Clinical Genetics Meeting March 2022 Natural history of arginase 1 deficiency and the unmet needs of patients: A systematic review of case reports Aseel Bin Sawad, Arti Pothukuchy, Mark Badeaux, Victoria Hodson, Gillian Bubb, Kristina Lindsley, Jennifer Uyei, George A. Diaz JIMD Reports March 2022 Arginase 1 Deficiency: Using Genetic Databases as a Tool to Establish Global Prevalence Catsburg, C., Anderson, S., Upadhyaya, N. et al Orphanet Journal of Rare Diseases December 2021 Treatment Outcomes with Pegzilarginase Compared with Standard of Care for Patients with Arginase 1 Deficiency Aseel Bin Sawad; John Jackimiec, Mark Bechter, Leslie Sloan, Scott Rowlinson, Kristina Lindsley, Anil Bhagat, Jennifer Uyei, George A Diaz International Conference on Rare Diseases and Orphan Drugs November 2021 Diagnosis of Arginase 1 Deficiency in a Patient With Cerebral Palsy Laura S. Farach, MD; David Rodriguez-Buritica, MD International Congress of Inborn Errors of Metabolism November 2021 Diagnosis and Long Term Treatment of Arginase 1 Deficiency Barbara K. Burton, MD International Congress of Inborn Errors of Metabolism November 2021 Arginine: The Key Driver of Pathophysiology and Progression in Arginase 1 Deficiency George A. Diaz, MD, PhD; Mark Bechter, BM; Stephen D. Cederbaum, MD International Congress of Inborn Errors of Metabolism November 2021 Patient Characteristics in the Pivotal Phase 3 PEACE Trial of Pegzilarginase Human Enzyme Therapy for Arginase 1 Deficiency Gregory M. Enns, MB, ChB; Rossana Sanchez Russo, MD; Gillian Bubb, PhD; Eric Bradford, MD, MSc, MBA; Serena Gasperini, MD; George A. Diaz, MD, PhD International Congress of Inborn Errors of Metabolism 123>> Get In Touch With Us View Contact Page
